These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21962342)

  • 1. Stability-based biomarker selection.
    Wehrens R; Franceschi P; Vrhovsek U; Mattivi F
    Anal Chim Acta; 2011 Oct; 705(1-2):15-23. PubMed ID: 21962342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted metabolomics for biomarker discovery.
    Griffiths WJ; Koal T; Wang Y; Kohl M; Enot DP; Deigner HP
    Angew Chem Int Ed Engl; 2010 Jul; 49(32):5426-45. PubMed ID: 20629054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processing and analysis of GC/LC-MS-based metabolomics data.
    Want E; Masson P
    Methods Mol Biol; 2011; 708():277-98. PubMed ID: 21207297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current practice of liquid chromatography-mass spectrometry in metabolomics and metabonomics.
    Gika HG; Theodoridis GA; Plumb RS; Wilson ID
    J Pharm Biomed Anal; 2014 Jan; 87():12-25. PubMed ID: 23916607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical analytical approach for the identification of biomarker candidates in prediabetic state based upon metabonomic study by ultraperformance liquid chromatography coupled to electrospray ionization time-of-flight mass spectrometry.
    Tsutsui H; Maeda T; Toyo'oka T; Min JZ; Inagaki S; Higashi T; Kagawa Y
    J Proteome Res; 2010 Aug; 9(8):3912-22. PubMed ID: 20557141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thresholding for biomarker selection in multivariate data using Higher Criticism.
    Wehrens R; Franceschi P
    Mol Biosyst; 2012 Sep; 8(9):2339-46. PubMed ID: 22744383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of valproic acid-induced endogenous and exogenous metabolite alterations using LC-MS-based metabolomics.
    Sun J; Schnackenberg LK; Hansen DK; Beger RD
    Bioanalysis; 2010 Feb; 2(2):207-16. PubMed ID: 21083304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of peak picking quality in LC-MS metabolomics data.
    Brodsky L; Moussaieff A; Shahaf N; Aharoni A; Rogachev I
    Anal Chem; 2010 Nov; 82(22):9177-87. PubMed ID: 20977194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease.
    Greenberg N; Grassano A; Thambisetty M; Lovestone S; Legido-Quigley C
    Electrophoresis; 2009 Apr; 30(7):1235-9. PubMed ID: 19288586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analytical strategy for biomarker identification based on liquid chromatography coupled to mass spectrometry and new candidate confirmation tools.
    Mohamed R; Varesio E; Ivosev G; Burton L; Bonner R; Hopfgartner G
    Anal Chem; 2009 Sep; 81(18):7677-94. PubMed ID: 19702294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review.
    Roux A; Lison D; Junot C; Heilier JF
    Clin Biochem; 2011 Jan; 44(1):119-35. PubMed ID: 20800591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic applications of HILIC-LC-MS.
    Cubbon S; Antonio C; Wilson J; Thomas-Oates J
    Mass Spectrom Rev; 2010; 29(5):671-84. PubMed ID: 19557839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipidomics in the study of lipid metabolism: Current perspectives in the omic sciences.
    Rolim AE; Henrique-Araújo R; Ferraz EG; de Araújo Alves Dultra FK; Fernandez LG
    Gene; 2015 Jan; 554(2):131-9. PubMed ID: 25445283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical search space reduction and two-dimensional data display approaches for UPLC-MS in biomarker discovery and pathway analysis.
    Crockford DJ; Lindon JC; Cloarec O; Plumb RS; Bruce SJ; Zirah S; Rainville P; Stumpf CL; Johnson K; Holmes E; Nicholson JK
    Anal Chem; 2006 Jul; 78(13):4398-408. PubMed ID: 16808447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminating variable test and selectivity ratio plot: quantitative tools for interpretation and variable (biomarker) selection in complex spectral or chromatographic profiles.
    Rajalahti T; Arneberg R; Kroksveen AC; Berle M; Myhr KM; Kvalheim OM
    Anal Chem; 2009 Apr; 81(7):2581-90. PubMed ID: 19228047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomic approach based on liquid chromatography coupled to high resolution mass spectrometry to screen for the illegal use of estradiol and progesterone in cattle.
    Regal P; Anizan S; Antignac JP; Le Bizec B; Cepeda A; Fente C
    Anal Chim Acta; 2011 Aug; 700(1-2):16-25. PubMed ID: 21742112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry: from proteomics to metabolomics and lipidomics.
    Griffiths WJ; Wang Y
    Chem Soc Rev; 2009 Jul; 38(7):1882-96. PubMed ID: 19551169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers.
    Woo HM; Kim KM; Choi MH; Jung BH; Lee J; Kong G; Nam SJ; Kim S; Bai SW; Chung BC
    Clin Chim Acta; 2009 Feb; 400(1-2):63-9. PubMed ID: 19010317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative/qualitative analysis using LC-HRMS: the fundamental step forward for clinical laboratories and clinical practice.
    Rochat B
    Bioanalysis; 2012 Jul; 4(14):1709-11. PubMed ID: 22877215
    [No Abstract]   [Full Text] [Related]  

  • 20. Integration of two-dimensional LC-MS with multivariate statistics for comparative analysis of proteomic samples.
    Gaspari M; Verhoeckx KC; Verheij ER; van der Greef J
    Anal Chem; 2006 Apr; 78(7):2286-96. PubMed ID: 16579610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.